Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With Psychosis

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 23, 2009

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions

SchizophreniaSchizoaffective DisorderPsychotic Disorder Not Otherwise SpecifiedSevere Bipolar Disorder With Psychotic Features

Interventions

DRUG

risperidone

3 levels of dosing dependent on which condition a patient is assigned to.

Trial Locations (1)

Zucker Hillside Hospital, Glen Oaks